ASN-001
ASN-001 is an orally active CYP-17A1 lyase inhibitor that selectively inhibits testosterone synthesis. ASN-001 has anticancer activity and can be used for research in the field of prostate cancer[1].
Product Specifications
CAS Number
[1429329-63-4]
UNSPSC
12352005
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/asn-001.html
Smiles
FC1=CC=C(C2=NC=C(C(C3=CC=NC=C3)(C)O)S2)C=C1
Molecular Formula
C16H13FN2OS
Molecular Weight
300.35
References & Citations
[1]Barata P, et al. Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy. Prostate. 2018 Sep;78 (13) :1035-1041.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
CYP17A1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx494542-01 96 Tests
Human Chymotrypsin-Like Elastase Family Member 3A (CELA3A) CLIA Kit
Ask
View Details abx494542-02 5x 96 Tests
Human Chymotrypsin-Like Elastase Family Member 3A (CELA3A) CLIA Kit
Ask
View Details abx494542-03 10x 96 Tests
Human Chymotrypsin-Like Elastase Family Member 3A (CELA3A) CLIA Kit
Ask
View Details 